Enhanced Inhibition of Syngeneic Murine Tumors by Combinatorial Therapy With Genetically Engineered HSV-1 Expressing CCL2 and IL-12
Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700784
Full Text
Open PDFAbstract
Available in full text
Date
January 28, 2005
Authors
Publisher
Springer Science and Business Media LLC